HeyJaredGlobal Regulatory News and Updates
Regulatory news, updates, and insights presented by the Carver Agents team
- Indexed episodes, last 90 days
- 12
- Latest publication
- Sep 21, 2026
- Audience
- Checking…
- Earliest in this view
- Jul 6, 2026
Latest episodes
Global Regulatory Roundup: Key Updates in Trade, AI & Tourism (opens the original)
Read excerpt
Covering Tourism, Artificial Intelligence, Trade, BPR, Foreign Direct Investment. Explore critical regulatory developments impacting Tourism, Artificial Intelligence, Trade, BPR, and Foreign Direct Investment sectors worldwide, including banking license revocation in Indonesia, EU trade enforcement, and Thailand’s tourism subsidies.
Global Regulatory Updates: ECB Rates, Neonate Nutrition & SEC Enforcement (opens the original)
Read excerpt
Covering ECB, Neonates, Financial Inclusion, Securities Exchange Act, Non-Clinical Package. This episode covers ECB interest rate changes, FDA guidance on neonatal nutrition compounding, SEC enforcement actions under the Securities Exchange Act, financial inclusion initiatives, and updates on non-clinical regulatory packages.
Regulatory Insights: Capital, WTO Talks, Innovation & SonicWall Fixes (opens the original)
Read excerpt
Covering Capital Requirements, WTO, Botanical Drug, Innovation Waiver, SonicWall. Explore key updates on capital requirements enforcement, WTO trade negotiations, botanical drug development, the Alaska Innovation Waiver forum, and critical SonicWall security patches. Stay informed on compliance and cybersecurity essentials.
Carver's Regulatory Update: Key Global Security & Finance Insights (opens the original)
Read excerpt
Covering Interest Rate, BPR Citra Bersada Abadi, Penjaminan, National Security, Insider Threat. This episode covers major regulatory developments across Interest Rate policies, BPR Citra Bersada Abadi deposit insurance, Penjaminan status, National Security enforcement, and Insider Threat prosecutions.
Global Regulatory Updates on FRIA, Salmon Protection & Acquisitions (opens the original)
Read excerpt
Covering Fundamental Rights Impact Assessment, Chinook Salmon, Acquisition, FRIA, Prescription Medicine. Explore key regulatory developments including the Fundamental Rights Impact Assessment for AI in the EU, Canada’s temporary Salmon River fish-protection order, and a major acquisition under antitrust review in China. Also covers prescription medicine advertising sanctions.
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
No verified audience measurement yet.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.